Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06854185 · ClinicalTrials.gov registry record · NA
Feasibility of the Paso Program for Patients With Metabolic Dysfunction Associated Steatotic Liver Disease
A NA study of Metabolic Syndrome and Metabolic Dysfunction Associated Steatotic Liver Disease, sponsored by Baylor College of Medicine.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06854185: Active NA study of Metabolic Syndrome and Metabolic Dysfunction Associated Steatotic Liver Disease, sponsored by Baylor College of Medicine.
NCT06854185 is a NA study of Metabolic Syndrome and Metabolic Dysfunction Associated Steatotic Liver Disease that is active but no longer recruiting, run by Baylor College of Medicine. The registered enrollment target is 50 participants, below the 1,204-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06854185, a NA study of Metabolic Syndrome and Metabolic Dysfunction Associated Steatotic Liver Disease, is active but no longer recruiting, sponsored by Baylor College of Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn whether the Paso weight loss program is feasible for Mexican and Central American patients with fatty liver disease. In addition, the investigators will also look at whether the program improves weight loss, fatty liver disease, physical activity, diet, and family support among patients.
Primary Outcome
Average attendance \> 8 sessions across participants
Conditions Studied
Interventions
- BEHAVIORAL Paso Program
Study Locations (1)
Texas
- Harris Health - Smith - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-02-05 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What the registry record for NCT06854185 still lists
NCT06854185 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,204-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with Metabolic Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Paso Program is the first listed.
NCT06854185 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06854185 about?
NCT06854185 is a clinical study titled "Feasibility of the Paso Program for Patients With Metabolic Dysfunction Associated Steatotic Liver Disease". The purpose of this study is to learn whether the Paso weight loss program is feasible for Mexican and Central American patients with fatty liver disease. In addition, the investigators will also look at whether the program improves weight loss, fatty liver disease, physical activity, diet, and fami...
What is the current status of trial NCT06854185?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-02-05. Estimated completion is 2026-12-31.
What conditions does trial NCT06854185 study?
This clinical trial studies the following conditions: Metabolic Syndrome, Metabolic Dysfunction Associated Steatotic Liver Disease, Overweight (BMI > 25).
What interventions are being tested in trial NCT06854185?
The interventions under investigation include: Paso Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06854185?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06854185 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolic Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06854185's enrollment target sits among peer trials
50 54th of 102 higher than 45 of 102 other Metabolic Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metabolic Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Animal and Plant Proteins and Glucose Metabolism
RECRUITING · NA
-
VR Stimulation of Exercise Response in Sedentary Humans
RECRUITING · NA
-
Impact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI